INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 417m ago
House PTR17m ago
SEC 13F16m ago
Robinhood Chain16m ago

Results

21,218 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
35
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$128K
6,675 sh
Sep 2, 2026Sep 3, 2026
Page 151 of 531
← PrevNext →
traded Sep 2, 2026
+1d
SEC Form 4

Evidence

35
JP
Jackson Jeremy PeterDirector, Chief Executive Officer
FLUTFlutter Entertainment plc
Open-market sale
SELL$172K
1,762 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

34
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$5.31M
166.5K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

34
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
33.5K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

32
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$102K
5,327 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

32
PS
Pariaros SymeonChief Administrative Officer
ESEAEUROSEAS LTD.
Open-market sale
SELL$75K
950 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

31
NC
Nueno CarlosPresident, International
TDOCTeladoc Health, Inc.
Open-market sale
SELL$39K
6,200 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

31
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale
SELL$46K
7,357 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

31
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$426K
16.1K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

28
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$612K
22.0K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

27
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$376K
5,900 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

27
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$810K
13.0K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

27
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$683K
10.9K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

27
CP
Campbell Darin PatrickDirector, President, Powersports Lending
OSBCOLD SECOND BANCORP INC
Open-market sale
SELL$613K
24.0K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

27
Jonathan L. JacksonDJoint
VSATVIASAT INC
Partial sale
SELL$1,001 – $15KAug 28, 2026Sep 3, 2026
traded Aug 28, 2026
+6dHouse PTR

Evidence

26
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
9,812 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

26
CE
Creviston Steven ESVP, Connectivity & Sensors
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$297K
2,958 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

25
Lantheus Holdings, Inc.10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$112K
35.8K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

25
BA
Bruggeworth Robert ADirector, President and CEO
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$1.68M
16.7K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

25
BA
Bruggeworth Robert ADirector, President and CEO
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$1.22M
12.0K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

24
WM
Willrath MatthewVP & CAO
GPORGULFPORT ENERGY CORP
Open-market sale
SELL$59K
325 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

23
CE
Creviston Steven ESVP, Connectivity & Sensors
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$188K
1,852 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

23
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$1.49M
52.9K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

22
KC
Kleinerman ChristianEVP, Product Management
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$4.88M
15.0K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

20
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
1,000 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

20
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Open-market sale · 10b5-1 plan
SELL$80K
22.2K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

20
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$320K
11.5K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

20
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
18.4K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

19
FJ
Fego Paul JSVP, Global Operations
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$240K
2,400 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

19
LC
Llewellyn Lindsay CatherineSEE REMARKS
LYFTLyft, Inc.
Open-market sale · 10b5-1 plan
SELL$220K
13.2K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

19
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.42M
13.3K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

19
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
5,439 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

18
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale · 10b5-1 plan
SELL$222K
34.1K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

17
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$113K
4,075 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$4.96M
15.2K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

16
FJ
Fego Paul JSVP, Global Operations
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$10K
100 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

15
GK
Guarini KathrynDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$340K
400 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

14
RS
Radhakrishnan SrikanthChief Science & Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$13K
5,863 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$54.02
2 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

14
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$746K
17.4K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence